Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti. - Wikidata - wikimedia - TriplyDB

Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.

Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.

http://www.wikidata.org/entity/Q33552968

about

Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection Cholera toxin B: one subunit with many pharmaceutical applications.Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis.Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV Infection A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia Antibody Secreting Cell Responses following Vaccination with Bivalent Oral Cholera Vaccine among Haitian Adults Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan.Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine.Comparison of immune responses to a killed bivalent whole cell oral cholera vaccine between endemic and less endemic settings.Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.Causes of impaired oral vaccine efficacy in developing countries.Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.Cholera: Immunity and Prospects in Vaccine Development Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial

P2860

Q27001897-346F3BB5-8834-40DC-9F1E-F76B417FCB54 Q35232735-AA5B3AAE-047C-401F-A8AC-D2BE2A726F4A Q35261144-F44B8434-F8B0-43C7-986D-86EE00594D84 Q35965212-73507D7E-CB42-443A-A631-C58F33077C44 Q36026263-7AB9A185-2ED2-42C9-AEF3-3D80642148AC Q36053849-2BC825FE-4502-4036-8F99-62438FEE8200 Q37360102-1F579398-0DF3-412A-BA9A-1E264F199FF0 Q38376033-C9752B5C-7A66-4A88-9177-FBD719799965 Q38979270-4C45710D-A0AE-4FC3-B427-D7184CE1D0F0 Q41039072-0E9A578A-CAC8-46CD-8FF6-77B6B37AEE9F Q41342001-A2053147-8FAC-463E-B597-93510B10A353 Q47794110-620320B1-A81A-4A18-AD22-6E0282E4005D Q48344793-1C62B9A2-B7BE-4318-89F6-FE35D728E048 Q57164819-EA87DAF6-F0F6-4565-AF7A-1ECF3A8B9761 Q57940864-43FAE4CF-92C0-4970-A4D2-A78693F23257

P2860

Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.

http://www.wikidata.org/entity/Q33552968

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@ast

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@en

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@nl

type

label

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@ast

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@en

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@nl

prefLabel

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@ast

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@en

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@nl

P1433

Q33552968-89846D7C-7303-4D90-AC55-3EB86E596624

P1476

Q33552968-A3DECF2D-13D9-45B6-B3B7-459B21690262

P2093

Q33552968-099ED477-AD0B-465D-8693-6E46026367B4

Q33552968-0CAFB54F-1E29-4A1B-865D-0C77CC85F808

Q33552968-1B3A493C-00A0-4C61-A0C0-2E1A8BB2E9A6

Q33552968-390257C3-28A3-4B05-9225-226DF5E413E8

Q33552968-474A33D1-D2FA-4715-88E7-DC1BEF24C26A

Q33552968-484B6746-7E4B-4F96-84C9-F5B5E46F089F

Q33552968-6734CF7A-D370-48A3-A259-3BC8CF7525F8

Q33552968-6CF8FCFE-9EB7-436E-B9B8-7C516BB3E136

Q33552968-92E2F46D-686A-42D9-BF36-F722B4E1FC23

Q33552968-C5275881-2CC5-4384-AE53-5F5146F5850A

P2860

Q33552968-02A168F7-909C-4A2C-A8C8-D2A7D7B478F2

Q33552968-037D0C2A-623D-400F-9AA1-417FABCFB1ED

Q33552968-0A6D3966-F54A-4E9B-AEF8-4A4BE966E95A

Q33552968-0ABE21A3-3885-4CD4-8A3C-31340E2FBAF6

Q33552968-0E8062E0-4BD9-4477-8059-8D62815D14EA

Q33552968-281F4729-9EF5-4420-BDC1-A69A30E92335

Q33552968-2987C874-0B75-42F5-BC45-63036F447424

Q33552968-2A1BBFC3-976F-4AAC-9939-34AB6A0DB9CA

Q33552968-31A18FBE-B101-4E8B-932D-80077267F8F6

Q33552968-3452158F-B69E-4324-B1F5-3C00FEF0347A

P304

Q33552968-FE5AF142-3651-4241-8DF8-BAE88C4897B8

P31

Q33552968-C111F698-08D8-416F-8739-079A6A2F0033

P356

Q33552968-043760F2-2256-4615-8758-33BD95EF596D

P407

Q33552968-D62989F7-FDF1-4592-86F1-4B49A419FE2B

P433

Q33552968-80CECC73-FFDF-4A00-84EB-5C72CB82DCF4

P478

Q33552968-4FF8DD63-BAE2-4CAE-A888-A301348CE2E3

P50

Q33552968-5B3C9881-2200-4223-80EA-5B890EF82B39

Q33552968-DB576E0A-4E19-4C63-A303-04B0601D380E

P577

Q33552968-3C81E094-63C7-41EB-A0E3-144B27829D9E

P5875

Q33552968-370D682E-3D57-4951-9252-4A865D1C63C3

P698

Q33552968-E8C111DC-713B-4E49-9201-34C79628FDA4

P921

Q33552968-9A25AE12-3D5B-4AD7-A6AA-794A347A886C

Q33552968-D88D25B0-A718-4084-874E-7DBA49FB0B0D

P932

Q33552968-88DB8E71-8202-48D8-AE66-584DD10DE87E

P356

JOURNAL.PNTD.0002828

P1433

PLOS Neglected Tropical Diseases

P1476

Immunogenicity of a killed biv ...... a vaccine, Shanchol, in Haiti.

@en

P2093

Amit Saha

http://www.w3.org/2001/XMLSchema#string

Charles P Almazor

http://www.w3.org/2001/XMLSchema#string

Edward T Ryan

http://www.w3.org/2001/XMLSchema#string

Isabelle J Hilaire

http://www.w3.org/2001/XMLSchema#string

J Gregory Jerome

http://www.w3.org/2001/XMLSchema#string

Jason B Harris

http://www.w3.org/2001/XMLSchema#string

Jessica E Teng

http://www.w3.org/2001/XMLSchema#string

Leslie M Mayo-Smith

http://www.w3.org/2001/XMLSchema#string

Louise C Ivers

http://www.w3.org/2001/XMLSchema#string

Paul Kováč

http://www.w3.org/2001/XMLSchema#string

P2860

The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa

Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera

Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: Molecular basis for serotype specificity

The origin of the Haitian cholera outbreak strain

The cholera pandemic, still with us after half a century: time to rethink.

Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh.

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.

Predisposition for cholera of individuals with O blood group. Possible evolutionary significance.

Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines.

Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.

P304

e2828

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PNTD.0002828

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262018209

http://www.w3.org/2001/XMLSchema#string

P698

24786645

http://www.w3.org/2001/XMLSchema#string

P921

P932

4006712

http://www.w3.org/2001/XMLSchema#string